Changes in sexual functioning in women of reproductive age with infertility and diminished ovarian reserve

Gavisova AA, Stenyaeva NN, Gardanova ZR, Nazarenko TA, Dolgushina NV
About authors

Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russia

Correspondence should be addressed: Alla A. Gavisova
Akademika Oparina, 4, Moscow, 117997; ur.ay@allaivag

About paper

Author contribution: Gavisova AA — analysis, manuscript writing, final approval; Gavisova AA, Dolgushina NV — study design; Stenyaeva NN, Gardanova ZR, Nazarenko TA, Dolgushina NV — review.

Compliance with ethical standards: the study was approved by the ethical review board at the Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology (protocol № 2 of 07 February 2019).

Received: 2022-08-26 Accepted: 2022-09-13 Published online: 2022-09-23
Figure. ROC curve for androstenedione
Table 1. Hormonal characteristics of patients in the study group
Note: data presented as median (lower and upper quartile); * — Mann–Whitney test, p < 0.05; LH — luteinizing hormone; FSH — follicle-stimulating hormone; Ttot — total testosterone; Tfr — free testosterone; DHT — dihydrotestosterone; DHEAS - dehydroepiandrosterone sulfate; 17-OP — 17-hydroxyprogesterone; A — androstenedione; AMH — anti-Müllerian hormone.
Table 2. Comparative assessment of the women's sexual functioning according to the FSFI questionnaire data (M ± SD)
Note: * — Student's t-test, p < 0,05.